Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti-inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies

Nusrat Jahan Moon , Mahathir Mohammad , Jahirul Islam Mamun , Fahmina Binty Azim Nova , Nazmul Hasan Eshaque , Hossain Rasel , Zobayed Islam , Mahmudul Hasan , Liakot Ali , Tanvir Chowdhury , S. M. Moazzem Hossen

Animal Models and Experimental Medicine ›› 2026, Vol. 9 ›› Issue (4) : 765 -784.

PDF (3436KB)
Animal Models and Experimental Medicine ›› 2026, Vol. 9 ›› Issue (4) :765 -784. DOI: 10.1002/ame2.70200
ORIGINAL ARTICLE
Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti-inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies
Author information +
History +
PDF (3436KB)

Abstract

Background: Adenostemma lavenia, a plant long used in traditional medicine to manage pain, inflammation, and circulatory disorders, has not been thoroughly validated using modern scientific methods. This study presents the first comprehensive investigation into the analgesic, anti-inflammatory, and thrombolytic potentials of the acetone extract of A. lavenia leaves (AEAL), employing an integrated strategy that combines in vivo, in vitro, and in silico methodologies.

Methods: The analgesic effects of the extract AEAL were evaluated in mice (five mice per group) using acetic acid-induced writhing, formalin-induced pain, and hot plate tests. Anti-inflammatory activity was assessed through xylene-induced ear edema in mice, heat-induced hemolysis of human red blood cells (HRBC), and protein denaturation assays. In vitro clot lysis was performed in triplicate to determine the thrombolytic activity of AEAL and a standard streptokinase. Molecular docking, density functional theory (DFT), and ADME/T profiling were conducted to identify and evaluate potential bioactive compounds.

Results: AEAL demonstrated significant, dose-dependent analgesic effects, reducing writhing responses by 53.74% (at 400 mg/kg), and inhibiting formalin-induced pain by up to 65.76% (p < 0.01). It also showed potent anti-inflammatory activity, with edema inhibition of 55.17% at a 400 mg/kg dose (p < 0.001), HRBC membrane stabilization (77.19%), and 85.96% suppression of protein denaturation. In thrombolytic testing, AEAL significantly (p < 0.001) achieved 68.1% clot dissolution compared with the control group. In silico analysis revealed that sesquiphellandrene strongly bound to COX-2 (−7.7 kcal/mol) and tissue plasminogen activator (tPA) (−6.9 kcal/mol), whereas derivatives of 2,3-hexadienoic acid exhibited notable COX-2 inhibition (−7.4 kcal/mol). ADMET predictions indicated favorable drug-like properties. In the DFT analysis, sesquiphellandrene and 2,3-hexadienoic acid, 2-methyl-4-phenyl-, methyl ester exhibited a narrow HOMO–LUMO energy gap, indicating high chemical reactivity and a greater propensity for electron-transfer processes.

Conclusions: The AEAL exhibits robust analgesic, anti-inflammatory, and thrombolytic activities, corroborated by computational analysis of its phytoconstituents. These results validate its ethnopharmacological use and highlight sesquiphellandrene as a promising candidate for future therapeutic development. Further isolation, mechanistic studies, and preclinical evaluation of sesquiphellandrene are warranted to harness its full pharmacological potential.

Keywords

Adenostemma lavenia / ADME/T / analgesic / DFT / HOMO–LUMO / in silico

Cite this article

Download citation ▾
Nusrat Jahan Moon, Mahathir Mohammad, Jahirul Islam Mamun, Fahmina Binty Azim Nova, Nazmul Hasan Eshaque, Hossain Rasel, Zobayed Islam, Mahmudul Hasan, Liakot Ali, Tanvir Chowdhury, S. M. Moazzem Hossen. Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti-inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies. Animal Models and Experimental Medicine, 2026, 9 (4) : 765-784 DOI:10.1002/ame2.70200

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Lima NN, Dolon NN, Maliha F, et al. An evaluation of analgesic and anti-inflammatory activity of Ficus racemosa in rat model. South Asian Res J Nat Prod. 2023; 6(3): 169-176.

[2]

Ricciotti E, GA FG. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31(5): 986-1000.

[3]

Twycross RG. Analgesics. Postgrad Med J. 1984; 60(710): 876-880.

[4]

Munir MA, Enany N, Zhang JM. Nonopioid analgesics. Anesthesiol Clin. 2007; 25(4): 761-774.

[5]

Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020; 180:114147.

[6]

Bjarnason I. Gastrointestinal safety of NSAIDs and over-the-counter analgesics. Int J Clin Pract. 2013; 67: 37-42.

[7]

Straube S, Tramèr MR, Moore RA, Derry S, HJ MQ. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol. 2009; 9(1):41.

[8]

Magaji A. Analgesic and anti-inflammatory activities of N-buthanol portion of Acacia nilotica pods in mice and Wistar rats. Int J Sci Res Manage. 2022; 10(1): 519-530.

[9]

Tabassum F, Chadni SH, Mou KN, Hasif KMI, Ahmed T, Akter M. In-vitro thrombolytic activity and phytochemical evaluation of leaf extracts of four medicinal plants of Asteraceae family. J Pharmacogn Phytochem. 2017; 6(4): 1166-1169.

[10]

Sherwani SK, Khan MM, Zubair A, Shah MA, Kazmi SU. Evaluation of in vitro thrombolytic activity of Bougainvillea spectabilis leaf extract. Int J Pharm Sci Rev Res. 2013; 21(1): 6-9.

[11]

Monie DD, EP DL. Pathogenesis of thrombosis: cellular and pharmacogenetic contributions. Cardiovasc Diagn Ther. 2017; 7(Suppl 3):S291.

[12]

Mackman N. Triggers, targets and treatments for thrombosis. Nature. 2008; 451(7181): 914-918.

[13]

Harun-Or-Rashid M, Akter S, Habiba U, et al. Antioxidant, antibacterial, cytotoxic and thrombolytic activities of flowers of Mirabilis jalapa L: possible role of phenolics and flavonoids. J Agric Food Res. 2023; 14:100893.

[14]

Mamun MJI, Mizan SI, Mohammad M, Ali ML, Ahsan MT. Exploring the neuropharmacological and antipyretic effects of Syzygium grande (Wight) Walp. methanolic leaf extract: an in vivo and computational study incorporating GC–MS/MS analysis. Food Sci Nutr. 2025; 13(10):e71088.

[15]

Obot IB, Gasem ZM, Umoren SA. Molecular level understanding of the mechanism of aloes leaves extract inhibition of low carbon steel corrosion: a DFT approach. Int J Electrochem Sci. 2014; 9(2): 510-522.

[16]

Pattanayak P, Behera P, Das D, Panda SK. Ocimum sanctum Linn. A reservoir plant for therapeutic applications: an overview. Pharmacogn Rev. 2010; 4(7):95.

[17]

El-Ayouty MM, Eltahawy NA, Abd El-Sameaa AM, et al. In vivo determination of analgesic and anti-inflammatory activities of isolated compounds from Cleome amblyocarpa and molecular modelling for the top active investigated compounds. RSC Adv. 2024; 14(34): 24503-24515.

[18]

Ahmed SR, Rabbee MF, Roy A, et al. Therapeutic promises of medicinal plants in Bangladesh and their bioactive compounds against ulcers and inflammatory diseases. Plants. 2021; 10(7):1348.

[19]

Chen JJ, Deng JS, Huang CC, et al. p-Coumaric-acid-containing Adenostemma lavenia ameliorates acute lung injury by activating AMPK/Nrf2/HO-1 signaling and improving the anti-oxidant response. Am J Chin Med. 2019; 47(7): 1483-1506.

[20]

Batubara I, Prastya ME. Potensi tanaman rempah dan obat tradisional Indonesia sebagai sumber bahan pangan fungsional. Seminar Nasional Lahan Suboptimal. Palembang: Penerbit & Percetakan Universitas Sriwijaya (UNSRI); 2020: 24-38.

[21]

Nurlela N, Nurfalah R, Ananda F, et al. Variation of morphological characteristics, total phenolic, and total flavonoid in Adenostemma lavenia, A. madurense, and A. platyphyllum. Biodiversitas. 2022; 23(8): 3999-4005.

[22]

Uddin M, Sarker M, Mamun MJI, Quader JMB, Alim MA, Meem JN. Medicinal attributes of Garuga pinnata Roxb.: a systematic exploration of its analgesic, antidiarrheal, hypoglycemic, and cytotoxic activities. Asian J Res Bot. 2025; 8(2): 537-554.

[23]

Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003; 290(7): 932-940.

[24]

Zaoui A, Cherrah Y, Mahassini N, Alaoui K, Amarouch H, Hassar M. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine. 2002; 9(1): 69-74.

[25]

Alam S, Emon NU, Shahriar S, et al. Pharmacological and computer-aided studies provide new insights into Millettia peguensis Ali (Fabaceae). Saudi Pharm J. 2020; 28(12): 1777-1790.

[26]

Hossen SMM, Hossain MS, Akbar S, Tahmida U, Mawa J, Emon NU. Wild mushrooms showed analgesic and cytotoxic properties along with phytoconstituent's binding affinity to COX-1, COX-2 and cytochrome P450 2C9. Heliyon. 2021; 7(9):e07997.

[27]

Mohammad M, Islam MA, Mamun MJ, et al. Methanolic extract of edible Lasia spinosa rhizome: a potential natural source of analgesic, diuretic, and thrombolytic agents. Int J Geogr Inf Syst. 2025; 31: 1-26.

[28]

Gaur K, Rana AC, Nema RK, Kori ML, Sharma CS. Anti-inflammatory and analgesic activity of hydro-alcoholic leaves extract of Euphorbia neriifolia Linn. Asian J Pharm Clin Res. 2009; 2(1): 26-28.

[29]

Hossen SMM, Islam MJ, Hossain MR, Barua A, Uddin MG, Emon NU. CNS anti-depressant, anxiolytic and analgesic effects of Ganoderma applanatum (mushroom) along with ligand-receptor binding screening provide new insights: multi-disciplinary approaches. Biochem Biophys Rep. 2021; 27:101062.

[30]

Yesmin S, Paul A, Naz T, et al. Membrane stabilization as a mechanism of the anti-inflammatory activity of ethanolic root extract of Choi (Piper chaba). Clin Phytoscience. 2020; 6: 1-10.

[31]

Sakat S, Juvekar AR, Gambhire MN. In vitro antioxidant and anti-inflammatory activity of methanol extract of Oxalis corniculata Linn. Int J Pharm Pharm Sci. 2010; 2(1): 146-155.

[32]

Sangeetha G, Vidhya R. In vitro anti-inflammatory activity of different parts of Pedalium murex (L.). Inflammation. 2016; 4(3): 31-36.

[33]

Hossain S, Rabbi SAH, Mamun MJI, et al. Antioxidant, anti-inflammatory, and neuropharmacological potential of Syngonium podophyllum flower methanolic extract: insights from in vivo, in vitro, in silico, and GC-MS/MS analysis. Chem Biodivers. 2025; 22:e202500425.

[34]

Emon NU, Alam S, Rudra S, et al. Antidepressant, anxiolytic, antipyretic, and thrombolytic profiling of methanol extract of the aerial part of Piper nigrum: in vivo, in vitro, and in silico approaches. Food Sci Nutr. 2021; 9(2): 833-846.

[35]

Mohammad M, Mamun MJI, Khatun MM, et al. A multifaceted exploration of Shirakiopsis indica (Willd) fruit: insights into the neuropharmacological, antipyretic, thrombolytic, and anthelmintic attributes of a mangrove species. Drugs Drug Candidates. 2025; 4(3):31.

[36]

Nahar A, Jahin Khandakar M, Jahirul Islam Mamun M, et al. Investigation of analgesic, anti-inflammatory, and thrombolytic effects of Methanolic extract and its fractions of Dischidia bengalensis: in vitro and in vivo studies with in silico interventions. Molecules. 2025; 30(18):3724.

[37]

Ali ML, Meem JN, Hoque N, et al. GC-MS analysis, neuropharmacological and antidiarrheal activities of the acetone extract of Najas gracillima seaweed: in vivo and in silico study. Chem Biodivers Published online. 2024; 22:e202402303.

[38]

Mamun MJI, Mizan SI, Mohammad M, Rasel MH, Uddin M. Deciphering the phytochemical and pharmacological potential of Syzygium grande (Wight) Walp. Through in vivo, in vitro, and computational approaches. Pharmacol Res Published online. 2026; 10:100509.

[39]

Akhter N, Alam M, Khan MRA, et al. Therapeutic potentials of Adenostemma lavenia (L.) O. Kuntze evidenced into an array of pharmacological effects and ligand-receptor interactions. Heliyon. 2023; 9(4):e15541.

[40]

Ali ML, Noushin F, Azme E, Hasan MM, Hoque N, Metu AF. Marine natural compounds as potential CBP bromodomain inhibitors for treating cancer: an in-silico approach using molecular docking, ADMET, molecular dynamics simulations and MM-PBSA binding free energy calculations. In Silico Pharmacol. 2024; 12(2): 1-20.

[41]

Masters L, Eagon S, Heying M. Evaluation of consensus scoring methods for AutoDock Vina, smina and idock. J Mol Graph Model. 2020; 96:107532.

[42]

Mamun MJI, Rasel MH, Chowdhury MT, et al. Biological and computational exploration of Ulva flexuosa: antioxidant, anti-inflammatory, antidiabetic, antipyretic, and cytotoxic insights for drug discovery. Pharmacol Res Published online. 2026; 10:100533.

[43]

Hasan MM, Alim MA, Momen MSH, et al. Harnessing the multidimensional bioactivity of Chaetomorpha aerea: integrative phytochemical profiling with in vitro, in vivo, and in silico insights. Anim Model Exp Med. 2025; 8: 1416-1427.

[44]

Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004; 1(4): 337-341.

[45]

Aati HY, Rauf A, Al-Qatani J, et al. GC-MS analysis, comprehensive biological profiling, molecular docking and ADMET studies of Ficus vasta Forssk. n-hexane extract. Future Sci OA. 2025; 11(1):2527021.

[46]

El-Demerdash SH, Halim SA, El-Nahas AM, El-Meligy AB. A density functional theory study of the molecular structure, reactivity, and spectroscopic properties of 2-(2-mercaptophenyl)-1-azaazulene tautomers and rotamers. Sci Rep. 2023; 13(1):15626.

[47]

Hernández-Fernández J, Puello-Polo E, Marquez E. Experimental–density functional theory (DFT) study of the inhibitory effect of furan residues in the Ziegler–Natta catalyst during polypropylene synthesis. Int J Mol Sci. 2023; 24(18):14368.

[48]

Mamun MJI, Rasel MH, Islam Z, Suma KJ, Uddin M. In vivo, in vitro, and in silico evaluation of the analgesic, antidiarrheal, and anthelmintic activities of methanolic extract of Syzygium grande (Wight) Walp. Pharmacol Res Mod Chin Med. 2025; 18:100734.

[49]

Mamun MJI, Alim MA, Tamim ST, et al. Pharmacological and computational insights into the analgesic, antipyretic, and antidiarrheal potential of Mallotus paniculatus acetone extract. Scientific World Journal. 2026; 2026(1):9813151.

[50]

Hasan MDM, Azme E, Alam R, et al. Mushrooms as potent autophagy modulators in cancer therapy: current evidence and therapeutic prospects. Cancer Pathog Ther. 2025; 4: 261-288.

[51]

Ferraz CR, Carvalho TT, Manchope MF, et al. Therapeutic potential of flavonoids in pain and inflammation: mechanisms of action, pre-clinical and clinical data, and pharmaceutical development. Molecules. 2020; 25(3):762.

[52]

Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001; 53(4): 597-652.

[53]

Bannister K, Dickenson AH. Central nervous system targets: supraspinal mechanisms of analgesia. Neurotherapeutics. 2020; 17(3): 839-845.

[54]

Maurya M. Antinociceptive activity of ethanolic neem (Azadirachta indica) leaf extract (enle) through opioid pathway in adult rats. J Pharmacol Clin Res. 2017; 3:555603.

[55]

Strzyga-Łach P, Czeczot H. The role of flavonoids in the modulation of inflammation. Pol Merkur Lekarski. 2016; 40(236): 134-140.

[56]

Kolodziejczyk-Czepas J, Czepas J. Plant-derived compounds and extracts as modulators of plasmin activity—a review. Molecules. 2023; 28(4):1677.

[57]

Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF. Effect of Fagonia arabica (Dhamasa) on in vitro thrombolysis. BMC Complement Altern Med. 2007; 7(1):36.

[58]

Bhowmick R, Sarwar MS, RahmanDewan SM, et al. In vivo analgesic, antipyretic, and anti-inflammatory potential in Swiss Albino mice and in vitro thrombolytic activity of hydroalcoholic extract from Litsea glutinosa leaves. Biol Res. 2014; 47: 1-8.

[59]

Teles Fujishima MA, da Silva N d SR, Ramos R d S, et al. An antioxidant potential, quantum-chemical and molecular docking study of the major chemical constituents present in the leaves of Curatella americana Linn. Pharmaceuticals. 2018; 11(3):72.

[60]

Tumilaar SG, Hardianto A, Dohi H, Kurnia D. Density functional theory, molecular docking study, and in vitro antioxidant activity of cinnamic acid isolated from Piper betle leaves. Biochem Res Int. 2025; 2025(1):1691257.

[61]

Chaachouay N. Synergy, additive effects, and antagonism of drugs with plant bioactive compounds. Drugs Drug Candidates. 2025; 4(1):4.

[62]

Leyva-López N, Gutierrez-Grijalva EP, Ambriz-Perez DL, Heredia JB. Flavonoids as cytokine modulators: a possible therapy for inflammation-related diseases. Int J Mol Sci. 2016; 17(6):921.

[63]

Verri JWA, Vicentini FTMC, Baracat MM, et al. Flavonoids as anti-inflammatory and analgesic drugs: mechanisms of action and perspectives in the development of pharmaceutical forms. Studies in Natural Products Chemistry. Elsevier. Vol 36; 2012: 297-330.

RIGHTS & PERMISSIONS

2026 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.

PDF (3436KB)

1

Accesses

0

Citation

Detail

Sections
Recommended

/